AHA GUIDELINES Bundle (free trial)

ACCF/AHA Device-Based Therapy Guidelines

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/112380

Contents of this Issue

Navigation

Page 10 of 19

����CRT may be considered for patients who have: ������ LVEF ���30%, ischemic etiology of HF, sinus rhythm, LBBB with a QRS duration ���150 ms, and NYHA class I symptoms on GDMT. (IIb-C) ������ LVEF ���35%, sinus rhythm, a non-LBBB pattern with a QRS duration 120-149 ms, and NYHA class III/ambulatory class IV on GDMT. (IIb-B) ������ LVEF ���35%, sinus rhythm, a non-LBBB pattern with a QRS duration ���150 ms, and NYHA class II symptoms on GDMT. (IIb-B) ����CRT is NOT recommended for patients: ������ with NYHA class I or II symptoms and non-LBBB pattern with QRS duration ��� <150 ms. (III-B: No Benefit) ������ whose comorbidities and/or frailty limit survival with good functional capacity to <1 year. (III-C: No Benefit) Pacing in Patients With Hypertrophic Cardiomyopathy (HCM) Treatment ����Permanent pacing is indicated for: ������ SND or AV block in patients with HCM as described previously (See ���Permanent Pacing in Sinus Node Dysfunction��� and ���Acquired Atrioventricular Block in Adults���). (I-C) ����Permanent pacing may be considered: ������ in medically refractory symptomatic patients with HCM and significant resting or provoked LV outflow tract obstruction. (IIb-A) As for Class I indications, when risk factors for SCD are present, consider a dual-chamber pacemaker that senses/paces in the atrium/ventricle and is inhibited/triggered by intrinsic rhythm (DDD) ICD (���See Implantable Cardioverter-Defibrillator���). ����Permanent pacemaker implantation is NOT indicated for: ������ patients who are asymptomatic or whose symptoms are medically controlled. ��� (III -C) ������ symptomatic patients without evidence of LV outflow tract obstruction. (III-C) Permanent Pacing in Children, Adolescents, and Patients With Congenital Heart Disease Key Points ����The most common indications for permanent pacemaker implantation in children, adolescents, and patients with congenital heart disease may be classified as: ������ symptomatic sinus bradycardia ������ the bradycardia-tachycardia syndromes ������ advanced second- or third-degree AV block, either congenital or postsurgical. 9

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - ACCF/AHA Device-Based Therapy Guidelines